Cost-effectiveness of automated telephone self-management support with nurse care management among patients with diabetes

Annals of Family Medicine

Volumn 6, Issue 6, 2008, Pages 512-518

  Handley, Margaret A ^a,b   Shumway, Martha ^b   Schillinger, Dean ^a,b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cost effectiveness; Diabetes; Disease management; Exercise; Health information technology; Practice based research; Self management support; Vulnerable populations

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; AUTOMATED TELEPHONE SELF MANAGEMENT SUPPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES EDUCATION; DIABETIC DIET; DIABETIC PATIENT; EXERCISE; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING CARE; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SELF MEDICATION;

EID: 56649098971     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.889     Document Type: Article

References (36)

1. Hoffman C, Rice D, Sung HY. Persons with chronic conditions. Their prevalence and costs. JAMA. 1996;276(18):1473-1479.
2. Narayan K, Zhang P, Kanaya A, et al. Disease Control Priorities in Developing Countries. 2nd ed. New York, NY: Oxford University Press; 2006:591-604.
3. Krein SL, Funnell MM, Piette JD. Economics of diabetes mellitus. Nurs Clin North Am. 2006;41(4):499-511, v-vi.
4. Krein SL, Heisler M, Piette JD, Makki F, Kerr EA. The effect of chronic pain on diabetes patients' self-management. Diabetes Care. 2005;28(1):65-70.
5. McCulloch DK, Price MJD, Hindmarsh M, Wagner EH. Improvement in diabetes care using an integrated population-based approach in a primary care setting. Dis Manage. 2000;3(2):75-82.
6. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics. 2004;22(3):149-164.
7. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-932.
8. Zhang P, Engelgau MM, Norris SL, Gregg EW, Narayan KM. Application of economic analysis to diabetes and diabetes care. Ann Intern Med. 2004;140(11):972-977.
9. Klonoff DC, Schwartz DM. An economic analysis of interventions for diabetes. Diabetes Care. 2000;23(3):390-404.
10. Glasziou P, Alexander J, Beller E, Clarke P, Group AC. Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes. 2007;5(21):1-11.
11. Guilkey DK, Hutchinson P, Lance P. Cost-effectiveness analysis for health communication programs. J Health Commun. 2006;11(Suppl 2):47-67.
12. Schillinger D, Handley M, Wang F, Hammer H. Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: a 3-arm randomized trial [abstract]. Presented at the 30th Society of General Internal Medicine Annual Meeting, Totonto, Canada, April 25-28, 2007.
13. Schillinger D, Hammer H, Wang F, et al. Seeing in 3-D: examining the reach of diabetes self-management support strategies in a public healthcare system. Health Educ Behav. 2007 May 18 [Epub ahead of print].
14. US Department of Health and Human Services. Healthy People 2010. Understanding and Improving Health. 2nd ed. Washington, DC: US Government Printing Office; November 2000.
15. American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care. 2007;30(Suppl 1):S4-S41.
16. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-932.
17. Handley MA, Hammer H, Schillinger D. Navigating the terrain between research and practice: a Collaborative Research Network (CRN) case study in diabetes research. J Am Board Fam Med. 2006;19(1):85-92.
18. McCollum M, Ellis S, Regensteiner J, Zhang W, Sullivan P. Minor depression and health status among US adults with diabetes mellitus. Am J Manag Care. 2007;13(2):65-72.
19. Piette JD. Interactive voice response systems in the diagnosis and management of chronic disease. Am J Manag Care. 2000;6(7):817-827.
20. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108(1):20-27.
21. Goldman LE, Handley M, Rundall TG, Schillinger D. Current and future directions in Medi-Cal chronic disease care management: a view from the top. Am J Manag Care. 2007;13(5):263-268.
22. Gold M, Siegal J, Russell L, Weinstein M. Cost-Effectivenes in Health and Medicine. The Report on the Panel on Cost-Effectiveness in Health in Medicine. New York, NY: Oxford University Press; 1996.
23. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851-859.
24. Pickard AS, Wang Z, Walton SM, Lee TA. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? Health Qual Life Outcomes. 2005;4(3):11.
25. Wolff N, Helminiak TW, Tebes JK. Getting the cost right in cost-effectiveness analyses. Am J Psychiatry. 1997;154(6):736-743.
26. Hutchinson P, Wheeler J. The cost-effectiveness of health communication programs: what do we know? J Health Commun. 2006;11(Suppl 2):7-45.
27. Crowe BL. Cost-effectiveness analysis of telemedicine. J Telemed Telecare. 1998;4(Suppl 1):14-17.
28. Shumway M, Boccellari A, O'Brien K, Okin R. Cost-effectiveness of clinical case management for ED frequent users: results of a randomized trial. Am J Emerg Med. 2008;26(2):155-164.
29. Muennig P. Designing and Conducting Cost-Effectiveness Analysis in Medicine and Health Care. San Francisco, CA: Jossey-Bass; 2002:298.
30. Gilmer T, Roze S, Valentine W, et al. Cost-effectiveness of diabetes case management for low income populations. Health Serv Res. 2007;45(5):1943-1959.
31. The CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287(19):2542-2551.
32. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med. 2008;358(7):661-665.
33. Sigal RJ, Kenny GP, Boule NG, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147(6):357-369.
34. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14(6):1523-1532.
35. Gill TM, Allore H, Guo Z. Restricted activity and functional decline among community-living older persons. Arch Intern Med. 2003;163(11):1317-1322.
36. Selby JV, Scanlon D, Lafata JE, Villagra V, Beich J, Salber PR. Determining the value of disease management programs. Jt Comm J Qual Saf. 2003;29(9):491-499.